New peptide analgesic, μ1-opioid receptor agonist tafalgin, in multimodal pain management. First results of using in a multidisciplinary hospital

V. E. Gruzdev; M. A. Anisimov; Yu. E. Ryabukhina; A. V. Oskolkov; P. A. Zeynalova

MD-Onco

ISSN 2782-3202 (Print)
ISSN 2782-6171 (Online)

User

eng | рус

MD-Onco

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Gruzdev V.E., Anisimov M.A., Ryabukhina Yu.E., Oskolkov A.V., Zeynalova P.A. New peptide analgesic, μ1-opioid receptor agonist tafalgin, in multimodal pain management. First results of using in a multidisciplinary hospital. MD-Onco. 2024;4(1):78-84. (In Russ.) https://doi.org/10.17650/2782-3202-2024-4-1-78-84

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2782-3202 (Print)
ISSN 2782-6171 (Online)

Editor-in-Chief

Davydov Mikhail M.

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

V. E. Gruzdev
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation